# Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response

> **NCT00518154** · PHASE2 · COMPLETED · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 7 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Pyridostigmine tablets

## Key facts

- **NCT ID:** NCT00518154
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-11
- **Final completion:** 2009-01
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2019-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00518154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00518154, "Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00518154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*